Walgreens Boots (NASDAQ:WBA) pared a bit of its decline amid a report that private equity firm Sycamore Partners is talking ...

Walgreens Boots Alliance Inc.’s chairman and biggest shareholder, Stefano Pessina, has dealmaking in his DNA. Yet finding a ...

Sycamore Partners has been speaking with private credit firms about debt financing for a potential deal, despite an earlier report that takeover talks had stalled.

Find out why Walgreens Boots Alliance (WBA) stock fell over 7% in extended trading and why the drugstore chain is suspending ...

Walgreens Boots Alliance Inc. tumbled Friday after suspending the quarterly dividend it’s paid for the past 92 years in a bid ...

A Wall Street Journal report noted that according to CNBC's David Faber, a prospective deal between Walgreens and New York ...

Pharmacy chain Walgreens has been struggling for over a year and has been in talks to sell to Sycamore Partners, a deal that is now "mostly dead." Meanwhile, some independent pharmacies are opting to ...

Many finance professionals -- and not a few investors -- consider Walgreens a juicy target for private equity players. In ...

Walgreens Boots (NASDAQ:WBA) rose 1.6% after the drugstore chain's CEO responded to recent takeover speculation. Walgreens ...

Walgreens Boots Alliance (NASDAQ:WBA) is set to announce the first quarter earnings on Friday, and investors will keep an eye on updates regarding reports of potential sale to Sycamore Partners.